6 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... advanced Chagas cardiomyopathy ... Trypanosomiasis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... #Candidiasis #candida ... #mucosal #IDSA ... #Prevention #Treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Summary Acute AIDP ... Campylobacter jejuni - HIV ... , CMV, EBV - Influenza ... tachycardia, reversible cardiomyopathy ... GQ1b IgG Antibody associated
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... Infections in HIV-AIDS ... Preventing CMV ... systemic therapy in preventing ... #IDSA #Prevention
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Treating Histoplasma Capsulatum ... Infections in HIV-AIDS ... #Prevention #Treatment
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
of HIV/AIDS patients ... be present: • AIDS ... keratitis, iritis • CMV ... Other Pathogens Associated ... • Histoplasma capsulatum